Articles
Change and innovation in the pharma supply chain: more of the same in 2019?
2018 has seen some of the most fundamental changes to the pharmaceutical industry– driven by serialisation requirements in the US and EU, as there has been a seismic shift towards a more digitalised supply chain. The...
Articles
Transforming The Life Sciences Supply Chain Through Blockchain
Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments?
With many serialization and track & trace regulations in the compliance period, and others (e.g., EU FMD, US DSCSA) on...
Articles
The need of innovation in the injectable business – a CDMO perspective
The world of drug development and manufacturing is undergoing a change. Nowhere is this more evident than in the rapid increase in complex compounds such as biologics.
This change is further compounded with the erosion of the once commanding ‘blockbuster’...
Articles
The importance of biometric functions to improving data quality in Clinical Trials
Reducing the costs associated with clinical trials is one of the pharmaceutical industry’s core challenges. Running a clinical trial is incredibly expensive and if a compound fails in the late phases, it can be catastrophic for its sponsor company.
One...
Articles
Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development
In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies,to decrease clinical study duration, and to...
Articles
Capitalizing on Digital Innovation to Enhance Delivery
The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You?
Janssen Supply Chain Vice President Remo Colarusso explains how the company is pioneering high-tech new strategies to perfect an age-old mandate: better anticipating...
Articles
How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden of Data Collection
Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment and much of the symptom burden occurs outside the clinical environment.
Oncology research is uniquely...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
